Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acadia Pharmaceuticals Inc

NASDAQ: ACAD · Life Sciences · 7 alerts · CIK 1070494

Share price
$18.67Close, Nov 16
Market cap
$3.23B
Shares outstanding
172.83MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acadia Pharmaceuticals Inc filings on SEC EDGAR ↗

8:21 PM ET Form 4
Insider Selling

Acadia Pharmaceuticals EVP, CFO Mark C. Schneyer Sells $69.3K of Stock

Mark C. Schneyer, EVP, CFO, sold 3,321 shares of Acadia Pharmaceuticals Inc at $20.88 a share, worth $69.3K in total on Oct 30, 2026. Shares held after the trade: 71,322 (-4.4%).

Value
$69.3K
Shares
3,321
Price
$20.88
Role
EVP, CFO
Holding change
-4.4%
Trade date
Oct 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.